Skip to main content

Advertisement

SpringerLink
Log in

Vaginal cancer

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Carcinoma of the vagina is an uncommon gynecologic cancer in the United States and throughout the world. Carcinoma in situ of the vagina and very early stage invasive carcinoma of the vagina may be treated with surgery. However, the standard therapeutic intervention for patients with carcinoma of the vagina is radiation therapy. In early stage vaginal carcinoma, radiation therapy is chosen for definitive treatment to preserve the anatomy and function of the vagina. In more advanced stages of vaginal carcinoma, radiation therapy is chosen as the standard treatment to avoid exenterative surgery, preserve anatomy and function, and to treat known or presumed lymph node metastasis. No randomized studies comparing irradiation alone versus irradiation and chemotherapy have been performed for patients with advanced carcinoma of the vagina. The standard therapy for patients with advanced cervical carcinoma is irradiation and concurrent cisplatin-based chemotherapy. Because the etiology and epidemiology of vaginal carcinoma appears identical to those of patients with invasive cervical carcinoma, patients with advanced vaginal carcinoma should be treated with irradiation and concurrent cisplatin-based chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Creasman WT, Phillips JL, Menck HR: The national cancer data base report on cancer of the vagina. Cancer 1998, 83:1033–1040.

    Article  PubMed  CAS  Google Scholar 

  2. Beller U, Sideri M, Maisonneuve P, et al.: Carcinoma of the vagina. J Epidemiol Biostat 2001, 6:141–152.

    PubMed  CAS  Google Scholar 

  3. Grigsby PW, Siegel BA, Dehdashti F: Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001, 19:3745–3749.

    PubMed  CAS  Google Scholar 

  4. Curtis P, Shepherd JH, Lowe DG, et al.: The role of partial colpectomy in the management of persistent vaginal neoplasia after primary treatment. Br J Obstet Gynaecol 1992, 99:587–589.

    PubMed  CAS  Google Scholar 

  5. Stock RG, Chen ASJ, Seski J: A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol Oncol 1995, 56:45–52.

    Article  PubMed  CAS  Google Scholar 

  6. Look KY: Organ sparing management for carcinoma of the vulva and vagina. Eur J Gynaecol Oncol 2000, 21:439–446.

    PubMed  CAS  Google Scholar 

  7. Kirkbride P, Fyles A, Rawlings GA, et al.: Carcinoma of the vagina: experience at the Princess Margaret Hospital. Gynecol Oncol 1995, 56:435–443.

    Article  PubMed  CAS  Google Scholar 

  8. Perez CA, Grigsby PW, Garipagaoglu M, et al.: Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 1999, 44:37–45.

    Article  PubMed  CAS  Google Scholar 

  9. Chyle V, Zagars GK, Wheeler JA, et al.: Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 1996, 35:891–905.

    Article  PubMed  CAS  Google Scholar 

  10. Pingley S, Shrivastava SK, Sarin R, et al.: Primary carcinoma of the vagina: Tata Memorial Hospital experience. Int J Radiat Oncol Biol Phys 2000, 46:101–108.

    Article  PubMed  CAS  Google Scholar 

  11. Stock RG, Mychalczak B, Armstrong JG, et al.: The importance of brachytherapy technique in the management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys 1992, 24:747–753.

    PubMed  CAS  Google Scholar 

  12. Leung S, Sexton M: Radical radiation therapy for carcinoma of the vagina: impact of treatment modalities on outcome: Peter MacCallum Cancer Institute experience 1970-1990. Int J Radiat Oncol Biol Phys 1992, 25:413–418.

    Google Scholar 

  13. Tewari KS, Cappuccini F, Puthawala AA, et al.: Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy. Cancer 2001, 91:758–770.

    Article  PubMed  CAS  Google Scholar 

  14. Nanavati PJ, Fanning J, Hilgers RD, et al.: High-doserate brachytherapy in primary stage I and II vaginal cancer. Gynecol Oncol 1993, 51:67–71.

    Article  PubMed  CAS  Google Scholar 

  15. Thigpen JT, Blessing JA, Homesley HD, et al.: Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group study. Gynecol Oncol 1986, 23:101–104.

    Article  PubMed  CAS  Google Scholar 

  16. Zanetta G, Lissoni A, Gabriele A, et al.: Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma. Gynecol Oncol 1997, 64:431–435.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology Mallinckrodt Institute of Radiology, Washington University Medical Center, 4939 Children's Place,Suite 5500, Box 8224, 63110, St. Louis, MO, USA

    Perry W. Grigsby MD

Authors
  1. Perry W. Grigsby MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grigsby, P.W. Vaginal cancer. Curr. Treat. Options in Oncol. 3, 125–130 (2002). https://doi.org/10.1007/s11864-002-0058-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-002-0058-4

Keywords

Search

Navigation